Cargando…
Growth hormone supplementation during ovarian stimulation in women with advanced maternal age undergoing preimplantation genetic testing for Aneuploidy
BACKGROUND: Studies have shown that supplementation with recombinant human GH (rh-GH) during ovarian stimulation (OS) may improve the ovarian response and clinical outcomes of IVF. However, it remains unclear whether GH is associated with the ploidy status of embryos, and therefore, is unable to exp...
Autores principales: | Sui, Yilun, Xiao, Min, Fu, Jing, Li, Lu, Xu, Yining, Lei, Caixia, Sun, Xiaoxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585718/ https://www.ncbi.nlm.nih.gov/pubmed/37858247 http://dx.doi.org/10.1186/s13048-023-01279-y |
Ejemplares similares
-
Growth hormone supplementation ameliorates blastocyst euploidy rates and improves pregnancy outcomes in women undergoing preimplantation genetic testing for aneuploidy cycles
por: Guo, Qingqing, et al.
Publicado: (2023) -
Different Strategies of Preimplantation Genetic Testing for Aneuploidies in Women of Advanced Maternal Age: A Systematic Review and Meta-Analysis
por: Shi, Wei-Hui, et al.
Publicado: (2021) -
Preimplantation genetic testing for aneuploidies screening is not diagnostic
por: Barad, David H.
Publicado: (2022) -
Is it necessary for young patients with recurrent implantation failure to undergo preimplantation genetic testing for aneuploidy?
por: Du, Yulin, et al.
Publicado: (2023) -
Association of ovarian stimulation and embryonic aneuploidy in in vitro fertilization cycles with preimplantation genetic testing: A narrative systematic review
por: Rodriguez-Purata, Jorge, et al.
Publicado: (2022)